Department of Pulmonary Medicine, AIIMS, Bhopal, Madhya Pradesh, India.
Department of Pediatrics, AIIMS, Bhopal, Madhya Pradesh, India. Correspondence to: Dr Bhavna Dhingra, Additional Professor, Department of Pediatrics, AIIMS, Bhopal, Madhya Pradesh, India.
Indian Pediatr. 2019 Mar 15;56(3):213-220.
Tuberculosis continues to haunt mankind since its discovery more than a century ago. Although commendable advancements have been made in the diagnosis as well as treatment, especially in the last couple of decades, the healthcare burden of this disease worldwide is immense. Continuously evolving medical science has provided recent changes in national guidelines along with discovery of newer anti-tubercular drugs after many decades. In view of WHO declaring tuberculosis as a global health emergency and strong commitment being reflected by Government of India whereby National Strategic Plan aims to eliminate tuberculosis by 2025, it is high time that we work collectively on the goal of tuberculosis elimination. This article sums up the updates on newer anti-tubercular drugs as well as the recent changes adopted in Revised National Tuberculosis Control Program.
结核病自一个多世纪前被发现以来一直困扰着人类。尽管在诊断和治疗方面取得了值得称赞的进展,尤其是在过去几十年中,但全球范围内这种疾病的医疗负担仍然巨大。不断发展的医学科学为国家指南提供了最新变化,并且在几十年后发现了新的抗结核药物。鉴于世界卫生组织宣布结核病为全球卫生紧急情况,以及印度政府所反映的强烈承诺,即国家战略计划旨在到 2025 年消除结核病,现在是我们共同努力实现结核病消除目标的时候了。本文总结了新的抗结核药物的最新进展以及修订后的国家结核病控制计划所采用的最新变化。